Bryn Mawr Capital Management Inc’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,703	Closed	-$553K	–	627
2015 Q1	$553K	Sell	15,703 -869	-5%	-$29.4K	0.07%	220
2014 Q4	$532K	Sell	16,572 -730	-4%	-$21.1K	0.07%	236
2014 Q3	$485K	Buy	+17,302	New	+$527K	0.05%	390
2013 Q3	–	Sell	-12,750	Closed	-$367K	–	674
2013 Q2	$367K	Buy	+12,750	New	+$351K	0.02%	290

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Bryn Mawr Capital Management Inc's BRLI Position: Q2 2015 in Review

Bryn Mawr Capital Management Inc sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 15,703 shares — an estimated $553K sold.

Bryn Mawr Capital Management Inc first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $553K in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Bryn Mawr Capital Management Inc reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 15,703 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $553K.
Bryn Mawr Capital Management Inc first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
Bryn Mawr Capital Management Inc's BIO-REFERENCE LABS INC-NEW- position peaked at $553K in Q1 2015.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q2 2015, filed 7 Aug 2015.